Skip to main content

Sanofi (NASDAQ: SNY) — Company Overview, News & Financial Data

Sanofi logo
SNY Sanofi
Sanofi primary media
Company profile

Sanofi

About

Explore United States companies

Sanofi is a global biopharmaceutical company headquartered in Paris, France, specializing in the research, development, manufacturing, and marketing of therapeutic healthcare solutions worldwide. The company operates across key healthcare segments including immunology, vaccines, oncology, neurology, rare diseases, and general medicines. Sanofi maintains extensive global commercial networks, advanced research and development hubs, and biologic manufacturing infrastructure to deliver prescription therapies, vaccines, and consumer health products to healthcare providers and patients across international markets.

Snapshot

Public USOwnership
1973Year founded
~75,000Employees
Paris, FranceHead office
Loading Map...
Global footprint

Operations

All Locations
Republic of France

Products and/or services of Sanofi

  • Immunology Therapies: Research, development, and global distribution of biologic medicines and monoclonal antibodies targeting chronic inflammatory conditions, severe asthma, atopic dermatitis, and autoimmune disorders across major international healthcare markets.
  • Vaccines Manufacturing: Large-scale production and commercial supply of pediatric, seasonal influenza, meningococcal, and booster vaccines supplying healthcare systems, governments, and immunisation programs across Europe, the Americas, and global regions.
  • Rare Disease Biopharmaceuticals: Specialized treatment portfolios addressing high-unmet-need genetic conditions, including lysosomal storage disorders, rare hematologic conditions, and metabolic diseases provided through specialized healthcare networks worldwide.
  • Neurology and Neuroscience Treatments: Development and commercial distribution of advanced central nervous system therapeutics and neurodegenerative disease treatments, focusing on multiple sclerosis and relapsing-remitting neuroinflammatory diseases across international markets.
  • Oncology and Immuno-Oncology Therapies: Targeted cancer therapeutics and tumor-targeted immunotherapies engineered for solid tumors and hematologic malignancies, manufactured across global biopharmaceutical production facilities for oncology treatment centers worldwide.
  • General Medicines and Diabetes Care: Prescription pharmaceuticals, insulin formulations, cardiovascular therapies, and mature prescription brand portfolios distributed across hospital networks, retail pharmacies, and global primary care markets.

Sanofi executive team

  • Mr. Paul HudsonCEO & Director
  • Mr. François-Xavier RogerExecutive VP & CFO
  • Ms. Madeleine RoachExecutive VP & Head of Business Operations
  • Mr. Thomas Kudsk LarsenHead of Investor Relations & General Medicines
  • Mr. Roy PapatheodorouExecutive VP & General Counsel
  • Mr. Pierre ChancelSenior Vice President of Global Diabetes and Senior Vice President of Global Marketing
  • Ms. Natalie BickfordExecutive VP & Chief People Officer
  • Mr. Olivier CharmeilExecutive Vice President of General Medicines
  • Fabrizio GaudiHead of Austrian, German & Swiss Operations
  • Mr. Erik WallströmHead of Therapeutic Area - Neurology Development